ArticleFrontiers in immunology2026

Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study.

Huiliang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.